Evaluation of the pharmacokinetic interactions of montmorillonite powder or loperamide on pyrotinib in healthy volunteers by Yike Wang, Dai Li, Dai Li, Tong Zhang, Sumei Xu, Sumei Xu, Yanxin Zhang, Yanxin Zhang, Kaijing Zhao, Shaorong Li, Kai Shen, Xiaomin Li, Xiaomin Li, Pingsheng Xu, Pingsheng Xu

Subjects: “…pyrotinib…”
Get full text

The toxicity and mechanisms of pyrotinib on male reproductive system by Xiao Hu, Zhongjian Pan, Jie Yang, Peng Zheng, Jian Tan, Zhipeng Xu, Huaming Tang, Jianpeng Hu

Subjects: “…pyrotinib…”
Get full text

Pyrotinib targeted EGFR/GRP78 mediated cell apoptosis in high EGFR gene copy number gastric cancer by Lingbo Bao, Xudong Wang, Xiuyong Liao, Dong Li, ChunXue Li, Nan Dai, Xiaoyan Dai, Jing Yang, Nana Hu, Xueling Tong, Zhenjie He, Yuancheng Zhao, Zheng Liu, Yue Hu, Jinlu Shan, Dong Wang, Mengxia Li, Qian Chen

Subjects: “…Pyrotinib…”
Get full text

De-escalated neoadjuvant nab-paclitaxel combined with pyrotinib and trastuzumab in intrinsic HER2-enriched breast cancer (NJMU-BC01): a multicenter, single-arm, phase 2 trialResear... by Hong Pan, Yi Ren, Mengyao Zha, Mingduo Liu, Xiaoan Liu, Hui Xie, Xiaoming Zha, Yi Zhao, Lin Chen, Tiansong Xia, Zhao Liu, Jing Tao, Hua Pan, Yue Sun, Wei Li, Cong Wang, Qiang Ding, Shui Wang, Wenbin Zhou

Subjects: Get full text

Comparative Analysis of Clinical Efficacy and Safety of Pyrotinib Plus Capecitabine versus Trastuzumab Emtansine (T-DM1) as Second-Line Treatment for HER2-Positive Advanced Breast... by Han H, Wang C, Jiang F, Sun P, Liu J

Subjects: Get full text

Corrigendum: The synergistic effects of pyrotinib combined with adriamycin on HER2-positive breast cancer by Chaokun Wang, Shuzhen Deng, Jing Chen, Xiangyun Xu, Xiaochen Hu, Dejiu Kong, Gaofeng Liang, Xiang Yuan, Yuanpei Li, Xinshuai Wang

Subjects: Get full text

Pyrotinib monotherapy for advanced HER2-positive esophageal adenocarcinoma with trastuzumab resistance and chemotherapy intolerance: a case report and literature review by Tao Wang, Mingyuan He, Wei Guan

Subjects: Get full text

The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer by Chaokun Wang, Shuzhen Deng, Jing Chen, Xiangyun Xu, Xiaochen Hu, Dejiu Kong, Gaofeng Liang, Xiang Yuan, Yuanpei Li, Xinshuai Wang

Subjects: Get full text

Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancer by Yongxia Li, Yongxia Li, Yong Li, Taolang Li, Mingyuan He, Mingyuan He, Jianying Chang, Jianying Chang, Hui Cao, Daiqin Luo, Daiqin Luo, Junyuan Lv, Yunbi Zou, Yuyan Zheng, Li Ran, Li Ran, Feiyue Yang, Li Huang, Xiaoming Cheng

Subjects: Get full text

Disitamab vedotin combined with pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report by Jianxin Chen, Jian Wang, Jian Wang, Qinhong Zheng

Subjects: Get full text

A Retrospective Real-World Study of Pyrotinib in HER-2 Positive Advanced Breast Cancer by Yang Z, Fu WD, Gu HY, Ding JL, Guo GL

Subjects: “…pyrotinib…”
Get full text

Pyrotinib-assisted whole brain radiotherapy alleviates HER2-positive advanced breast cancer and brain metastases: a prospective study in patients by Fulin Zhou, Fulin Zhou, Cui Zhang, Mingyuan He, Yu Ren, Hongshuang Yue, Zhihua Tan, Shaolin Zhang, Yong Li, Shu Liu, Shu Liu

Subjects: “…pyrotinib…”
Get full text

First-Line Pyrotinib Combination Therapy for HER2-Mutated Advanced NSCLC: A Retrospective Cohort Analysis by Yan Xiang, Meiling Zhang, Qian Wang, Jingwen Liu, Lulin Zeng, Ao Sun, Kaihua Lu

Subjects: Get full text

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer in first-line/second-line setting by Jian Zhang, Jian Zhang, Jian Zhang, Yuxin Mu, Yuxin Mu, Yuxin Mu, Hui Zhang, Chao Deng, Jiao Yang, Lu Gan, Qingmo Yang, Xuefeng Xu, Wanping Liang, Xiaowei Qi, Liang Xu

Subjects: Get full text